RANI · Categories · Form 4

RANI - SEC Form 4 insider transactions

Rani Therapeutics Holdings Inc. (RANI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RANI

• 178d
  SEC Form 4 filed by Director Bailey Vasudev Jaiprakash

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 181d
  SEC Form 4 filed by Director Bassan Abraham

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 186d
  Large owner South Cone Investments Limited Partnership sold $15,711,314 worth of shares (5,923,000 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 264d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 331d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 338d
  SEC Form 4 filed by Chief Scientific Officer Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 338d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 338d
  SEC Form 4 filed by Chief Executive Officer Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 338d
  SEC Form 4 filed by Chief Financial Officer Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 556d
  Large owner South Cone Investments Limited Partnership sold $10,141,674 worth of shares (3,829,360 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 696d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 765d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 765d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 765d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 765d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 765d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 859d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 870d
  Quiroga Cortes Isidoro Alfonso sold $10,582,982 worth of shares (5,265,165 units at $2.01) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 992d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1062d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1077d
  SEC Form 4 filed by South Cone Investments Limited Partnership

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1082d
  SEC Form 4 filed by South Cone Investments Limited Partnership

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1087d
  SEC Form 4 filed by South Cone Investments Limited Partnership

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1090d
  SEC Form 4 filed by South Cone Investments Limited Partnership

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 1096d
  SEC Form 4 filed by South Cone Investments Limited Partnership

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)

Other RANI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends